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Abstract
Independent of the cause and location, inflammation - 
even when minimal - has clear effects on gastrointes-
tinal morphology and function. These result in altered 
digestion, absorption and barrier function. There is 
evidence of reduced villus height and crypt depth, 
increased permeability, as well as altered sugar and 
peptide absorption in the small intestine after induc-
tion of inflammation in experimental models, which is 
supported by some clinical data. Identification of in-
flammatory factors which may promote the process of 
gastrointestinal dysfunction as well as clinical research 
to verify experimental observations of inflammatory 
modulation of gastrointestinal function are required. 
Moreover, nutritional strategies to support functional 
restitution are needed. 
© 2010 Baishideng. All rights reserved.
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INTRODUCTION
The gut mucosa is a highly organized structure that is 
adapted to the absorption of  dietary components from 
the gastrointestinal lumen. It is maintained by a critical 
balance between epithelial cell proliferation, differentia-
tion, migration and apoptosis[1]. A complex interplay 
between multiple signaling events within epithelial cells 
controlling extracellular signals either from neighboring 
cells (cell-cell or cell-matrix contacts) or from a distant 
origin (e.g. hormones) maintains the specific organiza-
tion and function of  these cells.
Inflammation, regardless of  its location or extent, 
sends many local and systemic signals, which in turn 
may cause changes in the intestine. Inflammation alters 
the metabolic status and elevates energy expenditure, 
fat metabolism and protein catabolism[2,3]. The intestine, 
however, has an inherent ability to adapt morphologi-
cally and functionally in response to internal and ex-
ternal environmental stimuli[4]. The adaptations include 
modifications of  the brush border membrane fluidity 
and permeability as well as up- and down-regulation of  
carrier-mediated transporter proteins.
Inflammatory processes initiate a cascade of  intestinal 
events which not only influence the mucosa itself  but may 
also affect the function and integrity of  remote organs 
and tissues. Interleukin-1β (IL-1β), for example, has both 
direct central and indirect peripheral depressant effects 
on appetite mechanisms, whereas plasma concentrations 
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of  tumor necrosis factor α (TNF-α) are associated with 
increases in energy expenditure[5,6]. Lymphocyte activation 
leads to increased glucose consumption which stimulates 
major glucose-transporter proteins (GLUT) and insulin 
receptors[7,8]. Increased expression of  insulin receptors is 
essential for immune cell division, size and survival, and 
IL-7 seems to be essential in this process[9]. 
This review gives a brief  overview of  some observa-
tions of  the morphological and functional changes in the 
non-inflamed part of  the small intestine that are caused 
by inflammatory events in other parts of  the body. 
MORPHOLOGICAL ALTERATIONS IN THE 
INTESTINAL MUCOSA 
Gastrointestinal dysfunction is a common complication 
in patients with traumatic brain injury (TBI)[10]. It is pro-
posed that TBI sets off  a sequence of  local and systemic 
inflammatory events. Hang et al[11,12] found increased 
TNF-α and IL-6 concentrations in the jejunal tissue of  
mice after parietal brain contusion induced by a weight-
dropping method. In this TBI model, Hang et al[11] dem-
onstrated rapidly developing histopathological damage 
of  the gut mucosa, including apoptosis of  epithelial 
cells, loss of  tight junctions and mitochondrial damage. 
They found reduced jejunal villus height, crypt depth 
and surface area as early as 3 h following induction of  
brain injury. 
Morphological alterations have been confirmed in 
rats. Chen et al[13] induced TBI by a weight-dropping 
method in male Wistar rats. Ileal tissue was analyzed 
5 d after brain injury. The villus height and crypt depth 
of  ileal samples were significantly decreased compared 
to healthy controls. The authors also noticed increased 
inflammatory markers, such as IL-1β, TNF-α, IL-6 and 
intracellular adhesion molecule-1 expression, in the ileal 
tissue. 
Sundaram et al[14] found similar alterations in the mu-
cosal structure in the non-inflamed part of  rabbit ileum 
after colitis induced by intragastrically inoculated mi-
crobes. Despite a clear increase in proinflammatory IL-10 
in duodenal, jejunal and ileal tissue samples, however, 
neither Barada et al[15] nor Mourad et al[16], observed any 
histological alterations in the non-inflamed small intestine 
of  colitis-induced rats. Colitis was induced by intracolonic 
administration of  iodoacetamide or 2,4,6-trinitrobenzene 
sulfonic acid. 
Morphological alterations in the small intestine in 
inflammatory bowel disease (IBD) patients are conflicting. 
Whereas Salem & Truelove[17] and Arvanitakis[18] found 
histological changes in the non-inflamed part of  the 
jejunum in almost 70% of  IBD patients, Soulé et al[19] only 
observed morphological abnormalities in less than 5% of  
patients.
In chronic heart failure patients, the presence of  en-
dothelial dysfunction is associated with increased levels 
of  inflammatory markers[20]. This may also induce mor-
phological changes in the intestine. Sandek et al[21] report-
ed thickening of  non-inflamed ileal walls and of  all parts 
of  the large intestine in chronic heart failure patients 
compared with control subjects of  similar age. The in-
crease in wall thickening was about 30% in the terminal 
ileum and almost 50% in the transverse colon. Increased 
bowel wall thickness in the small intestine is a frequent 
finding in various inflammatory-related conditions, such 
as acute ischemic colitis, IBD and food hypersensitiv-
ity[22,23].
To summarize, many of  the above-mentioned studies 
in animal models assume the contributory effects of  
inflammatory mediators to be, at least partly, behind the 
observed morphological changes in the small intestine. 
However, there is no clear opinion as to the degree or 
location of  inflammation or the quantity or quality of  
morphological changes in the small intestine. In addition, 
the possible route of  effects, whether e.g. via circulating 
mediators or the autonomic nervous system, remains to 
be clarified.
ALTERATIONS OF PERMEABILITY
Tight junctions are dynamic structures that limit the 
passive absorption of  hydrophilic molecules from the 
intestinal lumen, thereby being crucial in intestinal 
barrier mechanisms. 
Proinflammatory cytokines IL-1β and TNF-α in-
creased epithelial tight junction permeability in vitro 
in Caco-2 cells dose- and time-dependently[24,25]. This 
was mediated by an increase in myosin L chain kinase 
(MLCK) expression and activity, which in turn was 
mediated by a nuclear factor-κB-dependent increase in 
MLCK gene transcription[26,27]. In a rabbit jejunal ex vivo 
model, however, added IL-8 had no effect on passive 
tissue permeability measured with Cr-EDTA in Ussing-
type chambers[28]. Nevertheless, cytokines affected neu-
rotransmitter release and content, suggesting the leading 
role of  the autonomic nervous system[29]. 
Intestinal mucosal function can be assessed in vivo 
by measuring the permeability of  the mucosal barrier 
to small or large solutes as in a lactulose-mannitol test. 
Mannitol (M), a small sugar, passes through the cell 
membranes. Lactulose (L), a large molecule, is absorbed 
paracellularly through the tight junctions. Increased 
absorption of  lactulose can reflect mucosal leakiness, 
and decreased absorption of  mannitol can indicate a 
decreased functional absorptive area. In a rat model 
of  TBI, the L/M ratio increased significantly at 3 h 
following brain contusion and reached a peak level at 72 h, 
indicating rapidly increased permeability and disruption 
of  tight junctions between epithelial cells[11]. 
Feighery et al[30] measured ileal permeability ex vivo in 
Sprague Dawley rats after inducing brain injury. After 
cortical contusion, ileal segments were removed and 
mounted in Ussing chambers within 30 min. Signifi-
cantly reduced ileal barrier function was observed by 
monitoring fluxes of  C-mannitol crossing epithelial tight 
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junctions. The authors assumed this to be mediated by 
opening of  the tight junctions caused by disturbances 
in the autonomic nervous system or possibly also by 
hemorrhagic shock. In addition, cerebral stroke leads 
to immunodepression promoting gut barrier dysfunc-
tion, which has led to increased permeability in a mouse 
model[31].
In a colitis rat model, Fries et al[32] found leaky tight 
junctions in the non-inflamed duodenum and ileum 
where permeability was increased over 70% compared 
with healthy controls. This increase correlated positively 
with the macroscopic colon damage score. In this study, 
colitis was induced by intrarectal trinitrobenzene sulfonic 
acid. Changes in the permeability of  the non-inflamed 
part of  the small intestine have been previously noticed 
in Crohn’s disease (CD) patients[33]. Söderholm et al[34], 
however, found no changes in baseline permeability in 
surgical segments of  non-inflamed distal ileum of  CD 
patients. In spite of  this finding, intestinal tight junctions 
of  CD patients were noticed to be more reactive to lumi-
nal stimuli of  sodium caprate (a constituent of  milk fat 
affecting tight junctions) compared with ileal segments 
from colon cancer patients, who served as non-inflamed 
controls. The authors assumed that the altered function 
of  the small intestinal tight junctions was mediated via 
disturbed cytoskeletal contractility in inflamed patients.
Chronic heart failure patients showed a 35% increase 
in small intestinal permeability measured by the L/M 
test and a 29% decrease of  D-xylose absorption, which 
reflects a reduced activity of  passive carrier-mediated 
transport[21]. This may be due to diminished gut circulation 
contributing to local edema and leading to reduced 
barrier function and dysfunction of  transport proteins, 
but proinflammatory cytokines can also influence gut 
epithelial hyperpermeability. Furthermore, the possible 
effect of  long-term medication cannot be excluded with 
these patients. 
To sum up, increased permeability has been noticed 
in many experimental animal models of  inflammation, 
which is supported by some clinical observations. Al-
tered permeability is most likely mediated by open tight 
junctions, but the role of  inflammatory agents and the 
autonomic nervous system in this phenomenon remains 
to be studied. Changes in the barrier function may have 
implications for nutrient absorption as well as for mul-
tiple organ failure caused by increased systemic delivery 
of  luminal endotoxins.
ALTERATIONS OF INTESTINAL MOTILITY
Gastrointestinal motility is regulated by circulating and 
local hormones as well as neurotransmitters, mainly of  
the enteric nervous system. Release of  these agents, 
however, is regulated by the central nervous system 
(CNS). Brain-gut peptides, such as cholecystokinin 
(CCK), vasoactive intestinal peptide (VIP) and calcitonin 
gene-related peptide (CGRP), are important mediators in 
the regulation of  gastrointestinal motility. Several kinds 
of  stress, such as trauma, cold, and pain, can induce 
the release of  these peptides from the CNS and enteric 
nerves[35]. Even psychological stress inhibits small intes-
tinal motility by regulating the expression of  CCK and 
VIP[36].
Evidence of  inflammatory impact on gut motility 
and gastrointestinal transit is scarce. However, Hang 
et al[37] measured gastric distension, delayed gastric emp-
tying and intestinal dilatation in rats after brain contu-
sion induced by a weight-dropping method. They also 
noticed significant changes of  brain-gut peptides CCK, 
VIP and CGRP both in plasma and jejunum tissue, 
which were assumed to be involved in the pathogenesis 
of  gastrointestinal dysmotility due to systemic stress. 
ALTERATIONS OF NUTRIENT 
ABSORPTION
There is experimental and clinical evidence that intes-
tinal inflammation is often associated with altered mal-
absorption of  fluids, electrolytes and nutrients - in the 
inflamed as well as the non-inflamed parts of  the intes-
tine[16-18,33,38-40]. 
Lactose and sucrose are the major disaccharides in 
the human diet. Before absorption, they are hydrolyzed 
to monosaccharides by the microvillus membrane en-
zymes, lactase and sucrase. Luminal factors, hormones 
and growth factors regulate the expression of  these 
enzymes along the longitudinal and vertical axes of  the 
small intestine. The iodoacetamide-induced colitis model 
of  Jurjus et al[41] showed a transient reduction in jejunal 
lactase and sucrase expression on days two and four after 
colitis induction in rats. The same observation was made 
for the jejunal aminopeptidase and GLUT-5 expressions. 
Aminopeptidases are involved in protein digestion in 
the jejunum and ileum, and GLUT-5 is a fructose trans-
porter of  the small intestine. The expression of  lactase, 
aminopeptidases and brush border GLUT-5 returned to 
normal in the jejunum following the resolution of  co-
lonic inflammation. However, sucrase and crypt GLUT-5 
expression remained lower for four or more days. Jurjus 
et al[41] suggest that the reduced enzyme expressions are 
probably due to decreased translation or increased deg-
radation, or both, since transcriptional changes were not 
noticed. Previously, a significant reduction in disaccha-
ridase activity in the jejunum and ileum of  IBD patients 
has been noticed[18,33]. 
Chronic heart failure patients have reduced intestinal 
sugar absorption, determined by the follow-up of  uri-
nary recovery of  orally administered D-xylose[21]. This 
indicates diminished absorption due to alterations in pas-
sive carrier-mediated transport. However, the effects of  
circulation and heart function cannot be excluded. There 
is also an increased risk of  anemia among heart failure 
patients, but the mechanisms for this phenomenon are 
not entirely clear[42]. In addition to renal dysfunction and 
decreased renal blood flow, circulating neurohormonal 
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and proinflammatory cytokines appear to contribute to 
anemia in chronic heart disease.
Interleukins may modulate intestinal transport func-
tion. Some proinflammatory cytokines have been report-
ed to exert significant effects on central and peripheral 
regulation of  glucose metabolism, which may be related 
to the increased metabolic demands of  inflamed tissue. 
IL-6, IL-1α and IL-8 seem to improve the absorption of  
glucose ex vivo in rabbit jejunal tissue[28]. Intracerebroven-
tricular injection of  IL-1α enhances whole-body glucose 
metabolism and increases insulin levels[43]. No alterations 
were seen after intravenous administration of  the same 
dose. Anti-inflammatory IL-10 appears to have no role 
in the regulation of  jejunal nutrient transport[28]. 
TNF-α is an important inflammatory mediator that 
plays a central role in triggering inflammatory reactions. 
Absorption of  monosaccharide galactose in incubated 
rat intestinal rings is impaired by proinflammatory IL-
1β and TNF-α by 30%[44]. In an experimental model of  
sepsis, intravenous administration of  TNF-α inhibited 
intestinal D-fructose absorption in the rabbit jejunum 
by decreasing the expression of  the GLUT-5 transporter 
at the brush border membrane[45]. It also inhibited 
D-galactose transport across the apical membrane of  
the enterocyte in rabbit intestinal tissue preparations and 
brush border vesicles by reducing the amounts of  Na+/
glucose cotransporter protein (SGLT1) in the plasma 
membrane through a mechanism in which several 
protein-like kinases are involved[46]. 
Proinflammatory cytokines IL-1α and IL-8 signifi-
cantly increased L-proline absorption in vitro in the rab-
bit jejunal tissue[28]. However, in rats with intracolonic 
iodoacetamide-induced colitis, jejunal alanine absorption 
was reduced 30%-40% at two days following iodoacet-
amide administration[47].
Brain injury in a rat model increased the transport 
and uptake of  dipeptides, even though the villus height 
and surface area were demonstrated to be significantly 
decreased[48]. This process was carried out by increases 
in the intestinal brush border transporter PepT1, which 
transfers dipeptides from the intestinal lumen to entero-
cyte cytoplasm. Rat intestinal PepT1 can be up-regulated 
under the influence of  many factors including the dietary 
protein load[49]. Up-regulation of  this oligopeptide trans-
porter in the intestine suggests that the gut can increase 
the luminal transport of  dietary proteins in the form of  
di- and tripeptides during intestinal failure, independent 
of  changes in the mucosal surface area. This has phar-
macological implications as well, since PepT1 mediates 
the intestinal absorption of  some peptide-like drugs[50]. 
There is some evidence that PepT1 may even have a role 
in inflammatory processes, since it is up-regulated in the 
colonic epithelial cells of  patients with chronic ulcerative 
colitis and CD[51].
To summarize, the observations of  changed absorptive 
capacity of  the small intestine are mainly from animal 
models. Maldigestion of  carbohydrates and changes in 
transporters of  sugars and peptides have been noticed. 
The clinical relevance of  these observations remains to be 
elucidated. 
CONCLUSION
Systemic or local inflammation may influence the intestinal 
absorptive area, epithelial cells, and barrier function via 
released inflammatory mediators and products from 
activated immune cells. Knowledge regarding the interplay 
of  inflammation and intestinal function is scant. The 
molecular mechanisms of  these changes may differ in 
acute and chronic inflammation.
Even if  the number of  observations of  morphology, 
permeability, motility and digestion is limited, the results 
are interesting and indicate possible clinical relevance. 
Table 1 summarizes the existing in vivo evidence. Most 
of  the observations, however, have been made after TBI 
which is an extreme model for studying inflammatory re-
sponses in the intestine. Interesting early clinical results 
of  altered intestinal morphology and function have been 
obtained in chronic heart failure patients. Chronic heart 
failure is associated with increased levels of  inflamma-
tory markers related to so-called low-grade or minimal 
inflammation. 
More research is needed to verify these mainly ex-
perimental observations and to establish their possible 
clinical relevance.
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